Limits...
Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross sectional study.

Muhumuza S, Olsen A, Katahoire A, Nuwaha F - PLoS ONE (2013)

Bottom Line: Of the 285 children who took praziquantel, 142 (49.8%) developed side effects.Of the 725 children who did not take the drug, 522 (72.0%) reported fear of side effects as a major reason for non-uptake.Fear of side effects of praziquantel, lack of knowledge about schistosomiasis transmission and prevention and lack of teacher support are some of the major factors associated with low uptake.

View Article: PubMed Central - PubMed

Affiliation: Makerere University, School of Medicine, Child Health and Development Center, Kampala, Uganda. simonmhmz@yahoo.com

ABSTRACT

Background: In Uganda, the current national health sector strategic and investment plan underscores schistosomiasis as one of the diseases targeted for elimination by the year 2015. However, uptake of treatment among school children is unknown but suspected to be low. We estimated the uptake and predictors of preventive treatment with praziquantel.

Methods: In a cross sectional study carried out in Jinja district of Uganda, a random sample of 1,010 children in 12 primary schools was questioned about their uptake of praziquantel, knowledge and perceptions about schistosomiasis, support for taking preventive treatment and the dangers of taking praziquantel. The prevalence and mean intensity of infection with Schistosoma mansoni were determined.

Results: Self reported uptake of praziquantel at last mass treatment was 28.2% (95% confidence interval (CI): 22.9%-33.6%). Overall prevalence and mean intensity of S. mansoni infection was 35% (95% CI: 25.4%-37.9%) and 116.1 eggs per gram (epg) of stool (95% CI: 98.3-137.1) respectively. Uptake of praziquantel was more likely if a child was from a school with high prevalence of infection, had knowledge about schistosomiasis transmission and prevention, and reported teachers' support to take praziquantel. Of the 285 children who took praziquantel, 142 (49.8%) developed side effects. Of the 725 children who did not take the drug, 522 (72.0%) reported fear of side effects as a major reason for non-uptake.

Conclusions: Uptake of praziquantel in this population is very low. Fear of side effects of praziquantel, lack of knowledge about schistosomiasis transmission and prevention and lack of teacher support are some of the major factors associated with low uptake.

Show MeSH

Related in: MedlinePlus

Comparison between uptake of praziquantel and prevalence of S.mansoni.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3646788&req=5

pone-0063438-g001: Comparison between uptake of praziquantel and prevalence of S.mansoni.

Mentions: Uptake of praziquantel in schools with higher prevalence and intensity of infections was generally much higher than in the schools with low prevalence and intensity infection as is shown in Figure 1.


Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross sectional study.

Muhumuza S, Olsen A, Katahoire A, Nuwaha F - PLoS ONE (2013)

Comparison between uptake of praziquantel and prevalence of S.mansoni.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3646788&req=5

pone-0063438-g001: Comparison between uptake of praziquantel and prevalence of S.mansoni.
Mentions: Uptake of praziquantel in schools with higher prevalence and intensity of infections was generally much higher than in the schools with low prevalence and intensity infection as is shown in Figure 1.

Bottom Line: Of the 285 children who took praziquantel, 142 (49.8%) developed side effects.Of the 725 children who did not take the drug, 522 (72.0%) reported fear of side effects as a major reason for non-uptake.Fear of side effects of praziquantel, lack of knowledge about schistosomiasis transmission and prevention and lack of teacher support are some of the major factors associated with low uptake.

View Article: PubMed Central - PubMed

Affiliation: Makerere University, School of Medicine, Child Health and Development Center, Kampala, Uganda. simonmhmz@yahoo.com

ABSTRACT

Background: In Uganda, the current national health sector strategic and investment plan underscores schistosomiasis as one of the diseases targeted for elimination by the year 2015. However, uptake of treatment among school children is unknown but suspected to be low. We estimated the uptake and predictors of preventive treatment with praziquantel.

Methods: In a cross sectional study carried out in Jinja district of Uganda, a random sample of 1,010 children in 12 primary schools was questioned about their uptake of praziquantel, knowledge and perceptions about schistosomiasis, support for taking preventive treatment and the dangers of taking praziquantel. The prevalence and mean intensity of infection with Schistosoma mansoni were determined.

Results: Self reported uptake of praziquantel at last mass treatment was 28.2% (95% confidence interval (CI): 22.9%-33.6%). Overall prevalence and mean intensity of S. mansoni infection was 35% (95% CI: 25.4%-37.9%) and 116.1 eggs per gram (epg) of stool (95% CI: 98.3-137.1) respectively. Uptake of praziquantel was more likely if a child was from a school with high prevalence of infection, had knowledge about schistosomiasis transmission and prevention, and reported teachers' support to take praziquantel. Of the 285 children who took praziquantel, 142 (49.8%) developed side effects. Of the 725 children who did not take the drug, 522 (72.0%) reported fear of side effects as a major reason for non-uptake.

Conclusions: Uptake of praziquantel in this population is very low. Fear of side effects of praziquantel, lack of knowledge about schistosomiasis transmission and prevention and lack of teacher support are some of the major factors associated with low uptake.

Show MeSH
Related in: MedlinePlus